Holen Sie sich die Stockscreener-App
27.97
0.96%
-0.2708
Schlusskurs vom Vortag:
$28.24
Offen:
$29.09
24-Stunden-Volumen:
1,365
Relative Volume:
0.22
Marktkapitalisierung:
$6.90M
Einnahmen:
$64.22M
Nettoeinkommen (Verlust:
$-373.46M
KGV:
-11.46
EPS:
-2.44
Netto-Cashflow:
$-157.61M
1W Leistung:
-1.86%
1M Leistung:
+3.03%
6M Leistung:
+64,347%
1J Leistung:
+64,347%
1-Tages-Spanne:
$28.00
$29.09
1-Wochen-Bereich:
$27.94
$29.09
52-Wochen-Spanne:
$24.88
$31.22
Cue Health Inc Stock (HLTH) Company Profile
Firmenname
Cue Health Inc
Sektor
Branche
Telefon
858-412-8151
Adresse
4980 Carroll Canyon Road, Suite 100, San Diego
Compare HLTH vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HLTH
Cue Health Inc
|
28.00 | 6.90M | 64.22M | -373.46M | -157.61M | -2.44 |
VEEV
Veeva Systems Inc
|
262.71 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.29 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
62.76 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
64.50 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
93.54 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Cue Health Inc Aktie (HLTH) Neueste Nachrichten
Eye Cue Mental Health Offers Couples Therapy by Video - Greater Milwaukee Today
Cue Health Inc. (HLTH) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
CUE Stock Jumps Over 100% After Hours — What’s Driving The Rally? - Stocktwits
CUE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enterprise value to revenue forward of CUE HEALTH INC – OTC:HLTHQ - tradingview.com
Price to earnings forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Price to sales forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Enterprise value to EBIT forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Enterprise value to EBITDA forward of CUE HEALTH INC – OTC:HLTHQ - TradingView
Cue Biopharma (CUE) hires James Ahlers as CFO with equity and severance package - Stock Titan
Cue Biopharma Inc (CUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tema's AI ETF Targets Drug Discovery, Diagnostics and Robotics - Stock Titan
TUBI APPOINTS SHANNON OLIVAS AS HEAD OF COMMUNICATIONS AND PUBLICITY - Tubi
Needham reiterates Hold on Conmed stock amid sale exploration - Investing.com
Cue Biopharma names Dominic Borie as chief medical officer - Investing.com
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development - Yahoo Finance
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Cue Biopharma (Nasdaq: CUE) secures $50M private placement and grants over 1M RSUs - Stock Titan
Cue: The Market Is Paying $86M For A Drug It Doesn't Own (NASDAQ:CUE) - Seeking Alpha
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Biotech firm Cue Biopharma lines up $50M to push its immune disorder drugs - Stock Titan
Cue Health Inc. Actuals & Estimates (OTC:HLTHQ) - TradingView
Cue Biopharma Inc (CUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Temasek’s CFO is moving into a new power role - Fortune
Apple’s Eddy Cue honoured as the 2026 Entertainment Person of the Year - Apple
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy? - Yahoo Finance
Conmed Names John Gallagher as New Chief Financial Officer - The Globe and Mail
Cue Biopharma (NASDAQ: CUE) registers 551,724 pre-funded-warrant shares for resale - Stock Titan
CONMED Appoints John E. Gallagher as New Chief Financial Officer, Effective July 2026 - Minichart
Conmed names John Gallagher as CFO effective July 15 By Investing.com - Investing.com Australia
Conmed names John Gallagher as CFO effective July 15 - Investing.com
CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay - Stock Titan
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer - Business Wire
Cue Biopharma Inc (CUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cue Biopharma Inc (CUE) Institutional Confidence - TradingKey
Cue Biopharma, Inc. (CUE) Latest Stock News & Headlines - Yahoo Finance
Cue Biopharma adds two directors as four board members resign - Investing.com UK
CUE - Finviz
Apple’s Top Executive Uses a Whoop — What That Says About the Company’s $100 Billion Apple Watch Problem - Yahoo Finance
CUE Stock Price, Quote & Chart | CUE BIOPHARMA INC (NASDAQ:CUE) - ChartMill
Cue Biopharma CEO to present at Jefferies healthcare conference in NYC - Stock Titan
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference - Yahoo Finance
Apple’s Eddy Cue to Receive Entertainment Person of the Year Honor at Cannes Lions Festival - Variety
Why Is Cue Health Inc. (HLTHQ) Stock Down Today? - Meyka
Cue Biopharma reports Q1 loss, secures $30M financing - Investing.com UK
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments - The Manila Times
Cue Biopharma (CUE) boosts Q1 revenue, raises $30M and trims net loss - Stock Titan
[10-Q] Cue Biopharma, Inc. Quarterly Earnings Report - Stock Titan
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
New Cue Biopharma CEO gets 655,074-share option and 327,537 stock units - Stock Titan
CUE stock jumps over 100% after hours — what’s driving the rally? - MSN
Finanzdaten der Cue Health Inc-Aktie (HLTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.63%
0.02%
Kapitalisierung:
|
Volumen (24h):